Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome
Allan-Blitz LT, Goodrich J, Hu H, Akbari O, Klausner JD. Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome. J Interferon Cytokine Res. 2023 Jul;43(7):307-313. doi: 10.1089/jir.2023.0051. Epub 2023 Jun 29. PMID: 37384921; PMCID: PMC10354723.
What Long COVID Prevention Strategies Suggest About Its Pathophysiology
Allan-Blitz LT, Hu H, Klausner JD. What Long COVID Prevention Strategies Suggest About Its Pathophysiology. Open Forum Infect Dis. 2023 Sep 8;10(10):ofad466. doi: 10.1093/ofid/ofad466. PMID: 37822557; PMCID: PMC10563786.
Unique immune and inflammatory cytokine profiles may define long COVID syndrome
Allan-Blitz LT, Akbari O, Kojima N, Saavedra E, Chellamuthu P, Denny N, MacMullan MA, Hess V, Shacreaw M, Brobeck M, Turner F, Slepnev VI, Ibrayeva A, Klausner JD. Unique immune and inflammatory cytokine profiles may define long COVID syndrome. Clin Exp Med. 2023 Oct;23(6):2925-2930. doi: 10.1007/s10238-023-01065-6. Epub 2023 Apr 16. PMID: 37061998; PMCID: PMC10105906.
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection
Hanson BA, Visvabharathy L, Orban ZS, Jimenez M, Batra A, Liotta EM, DeLisle RK, Klausner JD, Cohen P, Padhye AS, Tachas G, Koralnik IJ. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 Nov;114:462-474. doi: 10.1016/j.bbi.2023.08.022. Epub 2023 Sep 11. PMID: 37704012; PMCID: PMC10718560.
Rehabilitation Improved Self-Reported Cognitive Skills in Individuals With Long COVID: An Observational Study
Saxon M, Jackson S, Seth M, Koralnik IJ, Cherney LR. Cognitive Rehabilitation Improved Self-Reported Cognitive Skills in Individuals With Long COVID: An Observational Study. Arch Phys Med Rehabil. 2025 Feb 22:S0003-9993(25)00538-6. doi: 10.1016/j.apmr.2025.02.009. Epub ahead of print. PMID: 39993494.
Vaccination prior to SARS-CoV-2 infection does not affect the neurologic manifestations of long COVID
Mukherjee S, Singer T, Venkatesh A, Choudhury NA, Perez Giraldo GS, Jimenez M, Miller J, Lopez M, Hanson BA, Bawa AP, Batra A, Liotta EM, Koralnik IJ. Vaccination prior to SARS-CoV-2 infection does not affect the neurologic manifestations of long COVID. Brain Commun. 2025 Jan 7;7(1):fcae448. doi: 10.1093/braincomms/fcae448. PMID: 39777257; PMCID: PMC11703551.
Cognitive functioning in patients with neuro-PASC: the role of fatigue, mood, and hospitalization status
Cahan J, Finley JA, Cotton E, Orban ZS, Jimenez M, Weintraub S, Sorets T, Koralnik IJ. Cognitive functioning in patients with neuro-PASC: the role of fatigue, mood, and hospitalization status. Front Neurol. 2024 Jun 27;15:1401796. doi: 10.3389/fneur.2024.1401796. PMID: 38994492; PMCID: PMC11236596.
Neuro- PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein
Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, Clark JR, Graham EL, Liotta EM, Tachas G, Penaloza-MacMaster P, Koralnik IJ. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front Immunol. 2023 May 29;14:1155770. doi: 10.3389/fimmu.2023.1155770. Erratum in: Front Immunol. 2023 Aug 24;14:1275925. doi: 10.3389/fimmu.2023.1275925. PMID: 37313412; PMCID: PMC10258318.
A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments
Margaret A Maglione, Jeffrey D Klausner, Patricia K Wirnkar, Ivan Fallarme, Rozhin Lak, Kimny Sysawang, Ning Fu, Sachi Yagyu, Aneesa Motala, Danica Tolentino, Susanne Hempel, A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments, Open Forum Infectious Diseases, Volume 12, Issue 4, April 2025, ofaf097, https://doi.org/10.1093/ofid/ofaf097